JPH11502202A - プリロカインおよびヒドロフルオロカーボンエーロゾル製剤 - Google Patents
プリロカインおよびヒドロフルオロカーボンエーロゾル製剤Info
- Publication number
- JPH11502202A JPH11502202A JP8527923A JP52792396A JPH11502202A JP H11502202 A JPH11502202 A JP H11502202A JP 8527923 A JP8527923 A JP 8527923A JP 52792396 A JP52792396 A JP 52792396A JP H11502202 A JPH11502202 A JP H11502202A
- Authority
- JP
- Japan
- Prior art keywords
- prilocaine
- group
- hfc
- base
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.1,1,1,2−テトラフルオロエタン、1,1,1,2,3,3,3−ヘプタフルオロプロパン 、およびこれらの組合せから成る群から選ばれたヒドロフルオロカーボン推進剤 と、 前記ヒドロフルオロカーボン推進剤の中で可溶化されたプリロカイン基剤と を含む組成物。 2.前記プリロカイン基剤とは異なる麻酔薬であって前記ヒドロフルオロカーボ ン推進剤の中で可溶化された麻酔薬をさらに含む請求項1記載の組成物。 3.前記麻酔薬が、プロカイン、コカイン、クロロプロカイン、テトラカイン、 メピヴァカイン、リドカイン、ブピヴァカイン、エティディオカイン、ロピヴァ カインおよびベンゾカインから成る群から選ばれている請求項2記載の組成物。 4.1,1,1,2−テトラフルオロエタンおよび1,1,1,2,3,3,3−ヘプタフルオロプロ パンから成る群から選ばれたヒドロフルオロカーボン推進剤と、 前記ヒドロフルオロカーボン推進剤の中で可溶化されたプリロカイン基剤とか ら実質的に成る組成物。 5.ヒドロフルオロカーボン推進剤にプリロカイン基剤を溶解させる方法であっ て、 液状および微細棒状から成る群から選ばれた物理的形態でプリロカイン基剤を 用意する過程と、 前記用意する過程からの前記プリロカイン基剤を、1,1,1,2−テトラフルオロ エタンおよび1,1,1,2,3,3,3−ヘプタフルオロプロパンから成る群から選ばれた ヒドロフルオロカーボン推進剤と組み合わせる過程と を含む方法。 6.ヒドロフルオロカーボン推進剤に薬剤を可溶化または浮游化させる方法であ って、 1,1,1,2−テトラフルオロエタン、1,1,1,2,3,3,3−ヘプタフルオロプロパンお よびこれらの組合せから成る群から選ばれたヒドロフルオロカーボン推進剤にプ リロカイン基剤を溶解させるとともに液体を生成する過程と、 可溶化および浮游化から成る群から選ばれた方法により、前記プリロカイン基 剤を可溶化剤または浮游化剤として用いて薬剤を前記液体に含ませる過程と を含む方法。 7.前記溶解させる過程および含ませる過程が同時に行われる請求項6記載の方 法。 8.前記溶解させる過程が、液状および微細棒状から成る群から選ばれた物理的 形態でプリロカイン基剤を用意する過程を含む請求項6記載の方法。 9.前記含ませる過程が浮游化によって行われ、前記薬剤が気管支拡張薬、抗炎 症薬、鎮咳薬、血管作用薬、血管収縮薬、抗生物質、ペプチド、ステロイド、酵 素、抗ヒスタミン薬、ベンゾジアゼピン、抗精神病薬、鎮静剤、ビタミン、ホル モン、酵素および受容体の阻害剤および作用薬、δ−アミノレブリン酸、防腐薬 および消毒薬から成る群から選ばれている請求項6記載の方法。 10.前記薬剤が血管収縮薬である請求項9記載の方法。 11.前記血管収縮薬がフェニルエフリンである請求項10記載の方法。 12.前記含ませる過程が可溶化によって行われ、前記薬剤がプリロカイン以外 の麻酔薬である請求項6記載の方法。 13.前記麻酔薬が、プロカイン、コカイン、クロロプロカイン、テトラカイン 、メピヴァカイン、リドカイン、ブピヴァカイン、エティディオカイン、ロピヴ ァカインおよびベンゾカインから成る群から選ばれている請求項12記載の方法 。 14.患者に麻酔を施す方法であって、 前記患者の麻酔を要する部位を特定する過程と、 1,1,1,2−テトラフルオロエタン、1,1,1,2,3,3,3−ヘプタフルオロプロパンお よびこれらの組合せから成る群から選ばれたヒドロフルオロカーボン推進剤と、 前記ヒドロフルオロカーボン推進剤の中に可溶化されたプリロカイン基剤とを 含む組成物を前記患者の前記部位に施用する過程と を含む方法。 15.前記施用する過程が前記組成物をエーロゾルとして噴霧吹き付けすること によって行われる請求項14記載の方法。
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/405,930 | 1995-03-17 | ||
US08/405,930 US5593661A (en) | 1993-03-29 | 1995-03-17 | Lidocaine aerosol anaesthetic |
US08/408,877 US5534242A (en) | 1994-05-02 | 1995-03-24 | Lidocaine-vasoconstrictor aerosol preparation |
US08/408,877 | 1995-03-24 | ||
US08/435,812 US5589156A (en) | 1994-05-02 | 1995-05-05 | Prilocaine and hydrofluourocarbon aerosol preparations |
US08/435,812 | 1995-05-05 | ||
PCT/CA1996/000122 WO1996029066A1 (en) | 1995-03-17 | 1996-03-04 | Prilocaine and hydrofluorocarbon aerosol preparations |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH11502202A true JPH11502202A (ja) | 1999-02-23 |
JP4117707B2 JP4117707B2 (ja) | 2008-07-16 |
Family
ID=27410659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52792396A Expired - Lifetime JP4117707B2 (ja) | 1995-03-17 | 1996-03-04 | プリロカインおよびヒドロフルオロカーボンエーロゾル製剤 |
Country Status (13)
Country | Link |
---|---|
US (1) | US5589156A (ja) |
EP (1) | EP0814793B1 (ja) |
JP (1) | JP4117707B2 (ja) |
CN (1) | CN1149080C (ja) |
AT (1) | ATE245025T1 (ja) |
AU (1) | AU710600B2 (ja) |
BR (1) | BR9607988A (ja) |
DE (1) | DE69629109T2 (ja) |
DK (1) | DK0814793T3 (ja) |
ES (1) | ES2203676T3 (ja) |
LU (1) | LU92402I2 (ja) |
PT (1) | PT814793E (ja) |
WO (1) | WO1996029066A1 (ja) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5593661A (en) * | 1993-03-29 | 1997-01-14 | Henry; Richard A. | Lidocaine aerosol anaesthetic |
EP0759744B1 (en) * | 1994-05-13 | 2001-10-17 | Aradigm Corporation | Narcotic containing aerosol formulation |
US6013245A (en) * | 1995-01-26 | 2000-01-11 | Glaxo Group Limited | Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant |
US5955098A (en) * | 1996-04-12 | 1999-09-21 | Flemington Pharmaceutical Corp. | Buccal non polar spray or capsule |
US5954688A (en) * | 1997-08-26 | 1999-09-21 | Queen's University At Kingston | Everting toroid device for delivering a drug into a body cavity |
US6200288B1 (en) | 1997-08-26 | 2001-03-13 | Queen's University At Kingston | Everting toroid device for insertion into a body cavity |
GB2332372B (en) * | 1997-12-08 | 2002-08-14 | Minnesota Mining & Mfg | Pharmaceutical aerosol compositions |
US6423298B2 (en) | 1998-06-18 | 2002-07-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pharmaceutical formulations for aerosols with two or more active substances |
DE19827178A1 (de) * | 1998-06-18 | 2000-04-27 | Boehringer Ingelheim Pharma | Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen |
KR100600423B1 (ko) * | 1998-06-18 | 2006-07-13 | 베링거 인겔하임 파마슈티칼즈, 인코포레이티드 | 2개 이상의 활성 물질을 포함하는 연무질 약제학적 제형 |
US6235265B1 (en) | 1998-10-28 | 2001-05-22 | Alliedsignal Inc. | Evaporative coolant for topical anesthesia comprising hydrofluorocarbons and/or hydrochlorofluorocarbons |
AU3162001A (en) * | 1999-12-21 | 2001-07-03 | Id-Pharma Gmbh | Medicament, a method for its production and the use thereof |
GB0015361D0 (en) * | 2000-06-22 | 2000-08-16 | Pharmasol Ltd | Improvements in pharmaceutical compositions |
CZ301676B6 (cs) * | 2001-03-30 | 2010-05-19 | Jagotec Ag | Farmaceutický suspenzní aerosolový prípravek pro inhalaci a použití soli karboxylové kyseliny |
US20040241103A1 (en) * | 2002-09-10 | 2004-12-02 | 3M Innovative Properties Company | Pharmaceutical aerosol compositions |
US20040076671A1 (en) * | 2002-10-21 | 2004-04-22 | Aletha Tippett | Methods and compositions for topical wound treatment |
US7785584B2 (en) * | 2003-08-13 | 2010-08-31 | Healthpoint, Ltd. | Ointment wound spray |
US7105006B2 (en) * | 2003-08-15 | 2006-09-12 | Stat Medical Devices, Inc. | Adjustable lancet device and method |
US20050123484A1 (en) * | 2003-10-02 | 2005-06-09 | Collegium Pharmaceutical, Inc. | Non-flammable topical anesthetic liquid aerosols |
US20060188449A1 (en) * | 2003-10-03 | 2006-08-24 | Jane Hirsh | Topical aerosol foams |
WO2005115336A2 (en) * | 2004-05-15 | 2005-12-08 | Collegium Pharmaceutical, Inc. | Sprayable formulations for the treatment of acute inflammatory skin conditions |
US20070190124A1 (en) * | 2004-06-07 | 2007-08-16 | Jie Zhang | Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs |
US20080019927A1 (en) * | 2004-06-07 | 2008-01-24 | Jie Zhang | Compositions and methods for dermally treating neuropathy with minoxidil |
US8741333B2 (en) | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for treating dermatitis or psoriasis |
US20070189978A1 (en) * | 2004-06-07 | 2007-08-16 | Jie Zhang | Compositions and methods for dermally treating musculoskeletal pain |
US20070196323A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs |
US8741332B2 (en) * | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for dermally treating neuropathic pain |
US20070189977A1 (en) * | 2004-06-07 | 2007-08-16 | Jie Zhang | Spray-on formulations and methods for dermal delivery of drugs |
US8907153B2 (en) | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
US20070196457A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs |
US20070196293A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Compositions and methods for treating photo damaged skin |
US20070196452A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Flux-enabling compositions and methods for dermal delivery of drugs |
US20070280972A1 (en) * | 2006-04-25 | 2007-12-06 | Zars, Inc. | Adhesive solid gel-forming formulations for dermal drug delivery |
US9265898B2 (en) * | 2007-09-12 | 2016-02-23 | Wolfe Tory Medical, Inc. | Applicator for oropharyngeal anesthetic |
US20090093547A1 (en) * | 2007-10-09 | 2009-04-09 | Sciele Pharma, Inc. | Compositions and Methods for Treating Premature Ejaculation |
FR2927256B1 (fr) * | 2008-02-13 | 2010-05-14 | Top Pharm Lab | Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation |
US8652443B2 (en) * | 2008-02-14 | 2014-02-18 | Precision Dermatology, Inc. | Foamable microemulsion compositions for topical administration |
WO2009128933A1 (en) * | 2008-04-15 | 2009-10-22 | Sarcode Corporation | Aerosolized lfa-1 antagonists for use in localized treatment of immune related disorders |
US8555875B2 (en) | 2008-12-23 | 2013-10-15 | Map Pharmaceuticals, Inc. | Inhalation devices and related methods for administration of sedative hypnotic compounds |
CN102093248B (zh) * | 2010-12-22 | 2013-12-04 | 蚌埠丰原医药科技发展有限公司 | 一种制备盐酸丙胺卡因的方法 |
WO2013096560A1 (en) * | 2011-12-20 | 2013-06-27 | Map Pharmaceuticals, Inc. | Excipient-free aerosol formulation |
US10231961B1 (en) | 2017-02-07 | 2019-03-19 | Genus Lifesciences Inc. | Pharmaceutical compositions and methods of using the same |
US10413505B1 (en) | 2017-02-07 | 2019-09-17 | Genus Lifesciences Inc. | Pharmaceutical compositions and methods of using the same |
US10149843B1 (en) | 2017-02-07 | 2018-12-11 | Gneus Lifescineces Inc. | Pharmaceutical compositions and methods of using the same |
CN112274498B (zh) * | 2020-11-09 | 2021-09-07 | 北京中泰邦医药科技有限公司 | 一种复方利多卡因气雾剂及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5380754A (en) * | 1988-02-29 | 1995-01-10 | Virotex Corporation | Topical composition enhancing healing of viral lesions |
US5225183A (en) * | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
GB8900267D0 (en) * | 1989-01-06 | 1989-03-08 | Riker Laboratories Inc | Narcotic analgesic formulations and apparatus containing same |
US5276032A (en) * | 1989-12-28 | 1994-01-04 | King O Newton | Vision aid and anesthetic composition |
US5118494A (en) * | 1990-03-23 | 1992-06-02 | Minnesota Mining And Manufacturing Company | Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
US5190029A (en) * | 1991-02-14 | 1993-03-02 | Virginia Commonwealth University | Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content |
GB9103302D0 (en) * | 1991-02-16 | 1991-04-03 | Smithkline Beecham Plc | Pharmaceutical formulations |
US5510339A (en) * | 1993-02-02 | 1996-04-23 | Mayo Foundation For Medical Education And Research | Method for the treatment of bronchial asthma by administration of topical anesthetics |
WO1994022422A1 (en) * | 1993-03-29 | 1994-10-13 | Henry Richard A | Lidocaine aerosol anaesthetic |
US5453445A (en) * | 1994-05-02 | 1995-09-26 | Henry; Richard A. | Lidocaine-phenylephrine aerosol preparation |
-
1995
- 1995-05-05 US US08/435,812 patent/US5589156A/en not_active Expired - Lifetime
-
1996
- 1996-03-04 EP EP96902844A patent/EP0814793B1/en not_active Expired - Lifetime
- 1996-03-04 AT AT96902844T patent/ATE245025T1/de active
- 1996-03-04 JP JP52792396A patent/JP4117707B2/ja not_active Expired - Lifetime
- 1996-03-04 DK DK96902844T patent/DK0814793T3/da active
- 1996-03-04 PT PT96902844T patent/PT814793E/pt unknown
- 1996-03-04 AU AU47113/96A patent/AU710600B2/en not_active Expired
- 1996-03-04 BR BR9607988-6A patent/BR9607988A/pt active IP Right Grant
- 1996-03-04 CN CNB961926457A patent/CN1149080C/zh not_active Expired - Lifetime
- 1996-03-04 ES ES96902844T patent/ES2203676T3/es not_active Expired - Lifetime
- 1996-03-04 WO PCT/CA1996/000122 patent/WO1996029066A1/en active IP Right Grant
- 1996-03-04 DE DE69629109T patent/DE69629109T2/de not_active Expired - Lifetime
-
2014
- 2014-03-18 LU LU92402C patent/LU92402I2/fr unknown
Also Published As
Publication number | Publication date |
---|---|
LU92402I2 (fr) | 2014-05-19 |
DE69629109D1 (de) | 2003-08-21 |
AU4711396A (en) | 1996-10-08 |
ATE245025T1 (de) | 2003-08-15 |
ES2203676T3 (es) | 2004-04-16 |
JP4117707B2 (ja) | 2008-07-16 |
EP0814793A1 (en) | 1998-01-07 |
DE69629109T2 (de) | 2004-04-15 |
CN1179103A (zh) | 1998-04-15 |
EP0814793B1 (en) | 2003-07-16 |
AU710600B2 (en) | 1999-09-23 |
DK0814793T3 (da) | 2003-12-01 |
US5589156A (en) | 1996-12-31 |
WO1996029066A1 (en) | 1996-09-26 |
MX9707073A (es) | 1998-08-30 |
BR9607988A (pt) | 1999-11-30 |
PT814793E (pt) | 2003-12-31 |
CN1149080C (zh) | 2004-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4117707B2 (ja) | プリロカインおよびヒドロフルオロカーボンエーロゾル製剤 | |
US5563153A (en) | Sterile topical anesthetic gel | |
JP2769925B2 (ja) | ベクロメタゾン17,21ジプロピオネートを含んで成るエアロゾル製剤 | |
DE69432224T2 (de) | Aerosole als darreichungsform mit cfc-freiem treibmittel | |
RU2327450C2 (ru) | Фармацевтические продукты и композиции, содержащие специфические антихолинергические средства, агонисты бета-2 и кортикостероиды | |
ES2217277T3 (es) | Aerosoles medicos que contienen propelente hidrofluorocarbonado. | |
DE69528769T2 (de) | Aerosolformulierung für arzneimittel enthaltend polyglycolisierte glyzeride | |
EP1492499B1 (en) | Formoterol and mometasone aerosol formulations | |
US5858331A (en) | Prilocaine and hydrofluorocarbon aerosol preparations | |
BRPI0308274B1 (pt) | formulação de formoterol superfino | |
EP1492500B1 (en) | Formoterol and ciclesonide aerosol formulations | |
PT96550A (pt) | Processo para a libertacao percutanea de ibuprofeno utilizando gel hidro-alcoolico | |
DE1492015A1 (de) | Verbesserte Verabreichungsform pharmazeutischer Praeparate | |
BG63906B1 (bg) | Фармацевтичен аерозолен състав | |
JP2002501884A (ja) | 点鼻用液剤 | |
AU2003215597A1 (en) | Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect | |
FR2651678A1 (fr) | Composition pharmaceutique a base de salmeterol et de dipropionate de beclometasone. | |
JP2002508319A (ja) | 上気道における炎症/アレルギーのための薬物でのホルモテロールの使用 | |
KR100316358B1 (ko) | 클로로플루오로카본 비함유 모메타손 푸로에이트 에어로졸 제형 | |
CA2215680C (en) | Prilocaine and hydrofluorocarbon aerosol preparations | |
AU7732798A (en) | A novel pharmaceutical composition for inhalation containing CR 2039 (Andolast) | |
WO2001007014A1 (en) | Formulations of steroid solutions for inhalatory administration | |
MXPA97007073A (en) | Preparations of prilocaine and hydrofluorocarb aerosol | |
JP2003089633A (ja) | 持続性点鼻剤 | |
CN115671051A (zh) | 一种丙酮酸钠鼻喷剂及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20050817 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070306 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070606 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070723 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070704 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070911 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071128 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080121 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080109 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080218 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080201 |
|
A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20080201 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080408 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080416 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110502 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110502 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120502 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130502 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |